Neuland Laboratories Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 3,850.1 million compared to INR 4,070.73 million a year ago. Revenue was INR 3,903.67 million compared to INR 4,151.37 million a year ago. Net income was INR 675.62 million compared to INR 845.44 million a year ago. Basic earnings per share from continuing operations was INR 52.66 compared to INR 65.9 a year ago. Diluted earnings per share from continuing operations was INR 52.66 compared to INR 65.9 a year ago.
For the full year, sales was INR 15,585.81 million compared to INR 11,911.98 million a year ago. Revenue was INR 15,711.25 million compared to INR 12,009.46 million a year ago. Net income was INR 3,000.79 million compared to INR 1,635.18 million a year ago. Basic earnings per share from continuing operations was INR 233.89 compared to INR 127.45 a year ago. Diluted earnings per share from continuing operations was INR 233.89 compared to INR 127.45 a year ago.